DNA Sequencing: Emerging Technologies and Applications
The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.
The study scope includes Sanger, next-generation and emerging sequencing technologies. The markets for sample preparation products, sequencing instruments and consumables, bioinformatics and sequencing services are given for 2010 and 2011, and also forecast through 2016.
BCC examines the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions and sequencing patents. The strategies of the main sequencing companies are discussed. The main sequencing services markets are described, including diagnostics, consumer, research and development (R&D) and applied.
BCC provides information for global markets, including North America, Europe and Asia-Pacific. Specific country forecasts include the U.S., the U.K., Germany, China and Japan.
John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.
- Synthetic Biology: Global Markets (BIO066F)
- Global DNA Read, Write and Edit Market (BIO193A)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045G)
- Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150C)
- Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing (BIO159A)
- The worldwide market for sequencing products will grow from an estimated $1.3 billion in 2010 to more than $3.3 billion by 2015, a compound annual growth rate (CAGR) of 20.5% over the next 5 years.
- Life-science research and drug discovery and development applications represent the two largest markets for DNA sequencing revenues, accounting for an estimated $920.1 million in 2010. These markets are forecast to grow at a compound annual growth rate (CAGR) of 13% to reach nearly $1.7 billion in 2015.
- Emerging applications, including personal genomics and clinical diagnostics, are forecast to account for $541.4 million by the year 2015, an increase from $15.5 million in 2010 representing a 103.5% compound annual growth rate (CAGR).
- The global DNA sequencing industry was worth $794.1 million in 2007. This is expected to reach $862.5 million in 2008 and $1.7 billion in 2013, a compound annual growth rate (CAGR) of 14.7%./li>
- Research and drug discovery/development generated global revenues of $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and $1.0 billion in 2013, for a CAGR of 9.7%.
- Commercial applications were valued at $193.6 million in 2007 and an estimated $218.8 million in 2008. This segment should reach $426.1 million in 2013, a CAGR of 14.3%.
- Projected sales for the worldwide DNA sequencing and proteomics markets are expected to rise at an AAGR (average annual growth rate) of 17.6% from $7.8 billion in 2004 to $17.5 billion in 2009.
- Drug discovery and healthcare currently are two of the largest market sectors, representing respectively, some 46% and 20% of revenues in 2004.
- The food and renewable resource sector will grow at a modest pace motivated by the production of genetically altered food products offering better nutritional benefits and lower product costs.
- The environment market sector has only begun to tap into the technology benefits and this basic research sector will grow given the possibility of new research fields that may emerge.